State key Laboratory of Bioelectronics, Southeast University, Nanjing 210096, China.
J Nanobiotechnology. 2010 Oct 29;8:25. doi: 10.1186/1477-3155-8-25.
In recent years, near-infrared fluorescence (NIRF)-labeled iron nanoparticles have been synthesized and applied in a number of applications, including the labeling of human cells for monitoring the engraftment process, imaging tumors, sensoring the in vivo molecular environment surrounding nanoparticles and tracing their in vivo biodistribution. These studies demonstrate that NIRF-labeled iron nanoparticles provide an efficient probe for cell labeling. Furthermore, the in vivo imaging studies show excellent performance of the NIR fluorophores. However, there is a limited selection of NIRF-labeled iron nanoparticles with an optimal wavelength for imaging around 800 nm, where tissue autofluorescence is minimal. Therefore, it is necessary to develop additional alternative NIRF-labeled iron nanoparticles for application in this area.
This study manufactured 12-nm DMSA-coated Fe3O4 nanoparticles labeled with a near-infrared fluorophore, IRDye800CW (excitation/emission, 774/789 nm), to investigate their applicability in cell labeling and in vivo imaging. The mouse macrophage RAW264.7 was labeled with IRDye800CW-labeled Fe3O4 nanoparticles at concentrations of 20, 30, 40, 50, 60, 80 and 100 μg/ml for 24 h. The results revealed that the cells were efficiently labeled by the nanoparticles, without any significant effect on cell viability. The nanoparticles were injected into the mouse via the tail vein, at dosages of 2 or 5 mg/kg body weight, and the mouse was discontinuously imaged for 24 h. The results demonstrated that the nanoparticles gradually accumulated in liver and kidney regions following injection, reaching maximum concentrations at 6 h post-injection, following which they were gradually removed from these regions. After tracing the nanoparticles throughout the body it was revealed that they mainly distributed in three organs, the liver, spleen and kidney. Real-time live-body imaging effectively reported the dynamic process of the biodistribution and clearance of the nanoparticles in vivo.
IRDye800CW-labeled Fe3O4 nanoparticles provide an effective probe for cell-labeling and in vivo imaging.
近年来,近红外荧光(NIRF)标记的铁纳米粒子已经被合成并应用于许多领域,包括标记人类细胞以监测植入过程、成像肿瘤、感测纳米粒子周围的体内分子环境以及追踪其体内生物分布。这些研究表明,NIRF 标记的铁纳米粒子为细胞标记提供了一种有效的探针。此外,体内成像研究显示 NIR 荧光团具有优异的性能。然而,对于成像波长在 800nm 左右、组织自发荧光最小的最佳近红外荧光标记铁纳米粒子的选择有限。因此,有必要开发其他替代的近红外荧光标记铁纳米粒子,以应用于该领域。
本研究制备了 12nm 的 DMSA 包覆的 Fe3O4 纳米粒子,并用近红外荧光染料 IRDye800CW(激发/发射,774/789nm)进行标记,以研究其在细胞标记和体内成像中的适用性。将 RAW264.7 小鼠巨噬细胞用浓度为 20、30、40、50、60、80 和 100μg/ml 的 IRDye800CW 标记的 Fe3O4 纳米粒子标记 24 小时。结果表明,纳米粒子有效地标记了细胞,对细胞活力没有显著影响。将纳米粒子通过尾静脉注射到小鼠体内,剂量为 2 或 5mg/kg 体重,并在 24 小时内间断对小鼠进行成像。结果表明,纳米粒子在注射后逐渐在肝脏和肾脏区域积累,在注射后 6 小时达到最大浓度,然后逐渐从这些区域中去除。对纳米粒子在体内的分布进行追踪后发现,它们主要分布在三个器官,即肝脏、脾脏和肾脏。实时活体成像有效地报告了纳米粒子在体内的生物分布和清除的动态过程。
IRDye800CW 标记的 Fe3O4 纳米粒子为细胞标记和体内成像提供了一种有效的探针。